U.S. flag

An official website of the United States government

New/Reinstated & Terminated Labeler Information

The information below identifies new/reinstated & terminated labelers. This page will be updated as new information is available so please check back often.

For definitions of optional and mandatory effective dates, please see the Medicaid National Drug Rebate Agreement (NDRA). Additionally, the Drug Manufacturer Contact Information contains Optional Effective Date, Termination Date (if applicable), and Legal, Invoice and Technical Contact information for each drug company participating in the MDRP. 

New/Reinstated Labelers

Labeler CodeLabeler NameOptional Effective Date (for State Coverage)Mandatory Effective Date (for State Coverage)
82228BRIDGEBIO PHARMA, INC.12/05/202404/01/2025
83723BOTANIX SB INC.12/02/202404/01/2025
83774PILNOVA PHARMA, INC.11/12/202404/01/2025
00299GALDERMA LABORATORIES, L.P.10/31/202401/01/2025
82867AGEPHA PHARMA USA, LLC10/23/202401/01/2025
73043DEVATIS, INC.10/22/202401/01/2025
73515AVVISTO THERAPEUTICS LLC10/17/202401/01/2025
83980IPCA LABORATORIES LTD10/09/202401/01/2025
83853INTRABIO, INC.10/03/202401/01/2025
82580ARS PHARMACEUTICALS OPERATIONS, INC.09/27/202401/01/2025
80005CARNEGIE PHARMACEUTICALS09/20/202401/01/2025
11797ITALFARMACO SPA08/28/202401/01/2025
83205ADAPTIMMUNE, LLC08/23/202401/01/2025
83745APOZEAL PHARMACEUTICALS, INC.08/20/202401/01/2025

Terminated Labelers

Labeler CodeLabeler NameEffective Date
72152SAGE THERAPEUTICS01/01/2025
52796BONGEO PHARMACEUTICALS, INC.01/01/2025
24510COLLEGIUM PHARMACEUTICAL, INC.01/01/2025
46017MYLAN CONSUMER HEALTHCARE, INC.01/01/2025

For questions, please contact MDRP Operations at MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on New/Reinstated & Terminated Labelers and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.

Page last updated on December 10, 2024